Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

Patients who recover from an acute episode of psychosis are frequently prescribed prophylactic antipsychotics for many years, especially if they are diagnosed as having schizophrenia. However, there is a dearth of evidence concerning the long-term effectiveness of this practice, and growing concern...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of psychiatry 2016-11, Vol.209 (5), p.361-365
Hauptverfasser: Murray, Robin M., Quattrone, Diego, Natesan, Sridhar, van Os, Jim, Nordentoft, Merete, Howes, Oliver, Di Forti, Marta, Taylor, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 5
container_start_page 361
container_title British journal of psychiatry
container_volume 209
creator Murray, Robin M.
Quattrone, Diego
Natesan, Sridhar
van Os, Jim
Nordentoft, Merete
Howes, Oliver
Di Forti, Marta
Taylor, David
description Patients who recover from an acute episode of psychosis are frequently prescribed prophylactic antipsychotics for many years, especially if they are diagnosed as having schizophrenia. However, there is a dearth of evidence concerning the long-term effectiveness of this practice, and growing concern over the cumulative effects of antipsychotics on physical health and brain structure. Although controversy remains concerning some of the data, the wise psychiatrist should regularly review the benefit to each patient of continuing prophylactic antipsychotics against the risk of side-effects and loss of effectiveness through the development of supersensitivity of the dopamine D2 receptor. Psychiatrists should work with their patients to slowly reduce the antipsychotic to the lowest dose that prevents the return of distressing symptoms. Up to 40% of those whose psychosis remits after a first episode should be able to achieve a good outcome in the long term either with no antipsychotic medication or with a very low dose.
doi_str_mv 10.1192/bjp.bp.116.182683
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891867024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1192_bjp_bp_116_182683</cupid><sourcerecordid>2315619302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-408cc56972b2295a481df087b3c43ebbd028a00ed8f93216c4bd4ecfdd59b1a63</originalsourceid><addsrcrecordid>eNp1kE1LHDEcxkNR6tb2A3iRgBcvs-Zt8nISEW0FwUPrsYS8jTvLzGZMMof99sbuqlDwlH_C7__LwwPACUZLjBW5sOtpaac68yWWhEv6BSwwE6TBjLcHYIEQEg0mLToC33Je1ytlRHwFR0RIRJQQC_D39yrOg4dT3rpVb0rqc8nQBjjGFKAzc-njnKGxcS6wrAIc4uapKSGNcEpxWm0H40rv4JwDjB00m9L_U8X6mC-_g8PODDn82J_H4PH25s_1r-b-4efd9dV946hQpWFIOtdyJYglRLWGSew7JIWljtFgrUdEGoSCl52iBHPHrGfBdd63ymLD6TE433lrpuc55KLHPrswDGYTanyNpcKSC0RYRc_-Q9dxTpuaThOKW44VRaRSeEe5FHNOodNT6keTthoj_dq9rt1rO9WZ6133ded0b57tGPz7xlvZFaB7qRlt6v1T-Pj7c-0LE46SYg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2315619302</pqid></control><display><type>article</type><title>Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Alma/SFX Local Collection</source><source>Cambridge University Press Journals Complete</source><creator>Murray, Robin M. ; Quattrone, Diego ; Natesan, Sridhar ; van Os, Jim ; Nordentoft, Merete ; Howes, Oliver ; Di Forti, Marta ; Taylor, David</creator><creatorcontrib>Murray, Robin M. ; Quattrone, Diego ; Natesan, Sridhar ; van Os, Jim ; Nordentoft, Merete ; Howes, Oliver ; Di Forti, Marta ; Taylor, David</creatorcontrib><description>Patients who recover from an acute episode of psychosis are frequently prescribed prophylactic antipsychotics for many years, especially if they are diagnosed as having schizophrenia. However, there is a dearth of evidence concerning the long-term effectiveness of this practice, and growing concern over the cumulative effects of antipsychotics on physical health and brain structure. Although controversy remains concerning some of the data, the wise psychiatrist should regularly review the benefit to each patient of continuing prophylactic antipsychotics against the risk of side-effects and loss of effectiveness through the development of supersensitivity of the dopamine D2 receptor. Psychiatrists should work with their patients to slowly reduce the antipsychotic to the lowest dose that prevents the return of distressing symptoms. Up to 40% of those whose psychosis remits after a first episode should be able to achieve a good outcome in the long term either with no antipsychotic medication or with a very low dose.</description><identifier>ISSN: 0007-1250</identifier><identifier>EISSN: 1472-1465</identifier><identifier>DOI: 10.1192/bjp.bp.116.182683</identifier><identifier>PMID: 27802977</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Analysis ; Antipsychotic Agents - administration &amp; dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - pharmacology ; Antipsychotics ; Brain research ; Brain structure ; Diabetes ; Dopamine ; Dopamine D2 receptors ; Drug dosages ; Drug use ; Health status ; Humans ; Long term ; Mental disorders ; Mortality ; NMR ; Nuclear magnetic resonance ; Nutrition research ; Physical training ; Psychiatrists ; Psychiatry ; Psychosis ; Psychotic Disorders - prevention &amp; control ; Psychotropic drugs ; Schizophrenia ; Schizophrenia - prevention &amp; control ; Secondary Prevention - standards ; Side effects</subject><ispartof>British journal of psychiatry, 2016-11, Vol.209 (5), p.361-365</ispartof><rights>Copyright © Royal College of Psychiatrists, 2016</rights><rights>The Royal College of Psychiatrists 2016.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-408cc56972b2295a481df087b3c43ebbd028a00ed8f93216c4bd4ecfdd59b1a63</citedby><cites>FETCH-LOGICAL-c379t-408cc56972b2295a481df087b3c43ebbd028a00ed8f93216c4bd4ecfdd59b1a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0007125000245364/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,12846,27924,27925,30999,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27802977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murray, Robin M.</creatorcontrib><creatorcontrib>Quattrone, Diego</creatorcontrib><creatorcontrib>Natesan, Sridhar</creatorcontrib><creatorcontrib>van Os, Jim</creatorcontrib><creatorcontrib>Nordentoft, Merete</creatorcontrib><creatorcontrib>Howes, Oliver</creatorcontrib><creatorcontrib>Di Forti, Marta</creatorcontrib><creatorcontrib>Taylor, David</creatorcontrib><title>Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?</title><title>British journal of psychiatry</title><addtitle>Br J Psychiatry</addtitle><description>Patients who recover from an acute episode of psychosis are frequently prescribed prophylactic antipsychotics for many years, especially if they are diagnosed as having schizophrenia. However, there is a dearth of evidence concerning the long-term effectiveness of this practice, and growing concern over the cumulative effects of antipsychotics on physical health and brain structure. Although controversy remains concerning some of the data, the wise psychiatrist should regularly review the benefit to each patient of continuing prophylactic antipsychotics against the risk of side-effects and loss of effectiveness through the development of supersensitivity of the dopamine D2 receptor. Psychiatrists should work with their patients to slowly reduce the antipsychotic to the lowest dose that prevents the return of distressing symptoms. Up to 40% of those whose psychosis remits after a first episode should be able to achieve a good outcome in the long term either with no antipsychotic medication or with a very low dose.</description><subject>Analysis</subject><subject>Antipsychotic Agents - administration &amp; dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotics</subject><subject>Brain research</subject><subject>Brain structure</subject><subject>Diabetes</subject><subject>Dopamine</subject><subject>Dopamine D2 receptors</subject><subject>Drug dosages</subject><subject>Drug use</subject><subject>Health status</subject><subject>Humans</subject><subject>Long term</subject><subject>Mental disorders</subject><subject>Mortality</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Nutrition research</subject><subject>Physical training</subject><subject>Psychiatrists</subject><subject>Psychiatry</subject><subject>Psychosis</subject><subject>Psychotic Disorders - prevention &amp; control</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><subject>Schizophrenia - prevention &amp; control</subject><subject>Secondary Prevention - standards</subject><subject>Side effects</subject><issn>0007-1250</issn><issn>1472-1465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LHDEcxkNR6tb2A3iRgBcvs-Zt8nISEW0FwUPrsYS8jTvLzGZMMof99sbuqlDwlH_C7__LwwPACUZLjBW5sOtpaac68yWWhEv6BSwwE6TBjLcHYIEQEg0mLToC33Je1ytlRHwFR0RIRJQQC_D39yrOg4dT3rpVb0rqc8nQBjjGFKAzc-njnKGxcS6wrAIc4uapKSGNcEpxWm0H40rv4JwDjB00m9L_U8X6mC-_g8PODDn82J_H4PH25s_1r-b-4efd9dV946hQpWFIOtdyJYglRLWGSew7JIWljtFgrUdEGoSCl52iBHPHrGfBdd63ymLD6TE433lrpuc55KLHPrswDGYTanyNpcKSC0RYRc_-Q9dxTpuaThOKW44VRaRSeEe5FHNOodNT6keTthoj_dq9rt1rO9WZ6133ded0b57tGPz7xlvZFaB7qRlt6v1T-Pj7c-0LE46SYg</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Murray, Robin M.</creator><creator>Quattrone, Diego</creator><creator>Natesan, Sridhar</creator><creator>van Os, Jim</creator><creator>Nordentoft, Merete</creator><creator>Howes, Oliver</creator><creator>Di Forti, Marta</creator><creator>Taylor, David</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7TK</scope><scope>7XB</scope><scope>88G</scope><scope>88J</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>M2M</scope><scope>M2O</scope><scope>M2R</scope><scope>M2S</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>201611</creationdate><title>Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?</title><author>Murray, Robin M. ; Quattrone, Diego ; Natesan, Sridhar ; van Os, Jim ; Nordentoft, Merete ; Howes, Oliver ; Di Forti, Marta ; Taylor, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-408cc56972b2295a481df087b3c43ebbd028a00ed8f93216c4bd4ecfdd59b1a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analysis</topic><topic>Antipsychotic Agents - administration &amp; dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotics</topic><topic>Brain research</topic><topic>Brain structure</topic><topic>Diabetes</topic><topic>Dopamine</topic><topic>Dopamine D2 receptors</topic><topic>Drug dosages</topic><topic>Drug use</topic><topic>Health status</topic><topic>Humans</topic><topic>Long term</topic><topic>Mental disorders</topic><topic>Mortality</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Nutrition research</topic><topic>Physical training</topic><topic>Psychiatrists</topic><topic>Psychiatry</topic><topic>Psychosis</topic><topic>Psychotic Disorders - prevention &amp; control</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><topic>Schizophrenia - prevention &amp; control</topic><topic>Secondary Prevention - standards</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murray, Robin M.</creatorcontrib><creatorcontrib>Quattrone, Diego</creatorcontrib><creatorcontrib>Natesan, Sridhar</creatorcontrib><creatorcontrib>van Os, Jim</creatorcontrib><creatorcontrib>Nordentoft, Merete</creatorcontrib><creatorcontrib>Howes, Oliver</creatorcontrib><creatorcontrib>Di Forti, Marta</creatorcontrib><creatorcontrib>Taylor, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>British journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murray, Robin M.</au><au>Quattrone, Diego</au><au>Natesan, Sridhar</au><au>van Os, Jim</au><au>Nordentoft, Merete</au><au>Howes, Oliver</au><au>Di Forti, Marta</au><au>Taylor, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?</atitle><jtitle>British journal of psychiatry</jtitle><addtitle>Br J Psychiatry</addtitle><date>2016-11</date><risdate>2016</risdate><volume>209</volume><issue>5</issue><spage>361</spage><epage>365</epage><pages>361-365</pages><issn>0007-1250</issn><eissn>1472-1465</eissn><abstract>Patients who recover from an acute episode of psychosis are frequently prescribed prophylactic antipsychotics for many years, especially if they are diagnosed as having schizophrenia. However, there is a dearth of evidence concerning the long-term effectiveness of this practice, and growing concern over the cumulative effects of antipsychotics on physical health and brain structure. Although controversy remains concerning some of the data, the wise psychiatrist should regularly review the benefit to each patient of continuing prophylactic antipsychotics against the risk of side-effects and loss of effectiveness through the development of supersensitivity of the dopamine D2 receptor. Psychiatrists should work with their patients to slowly reduce the antipsychotic to the lowest dose that prevents the return of distressing symptoms. Up to 40% of those whose psychosis remits after a first episode should be able to achieve a good outcome in the long term either with no antipsychotic medication or with a very low dose.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>27802977</pmid><doi>10.1192/bjp.bp.116.182683</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1250
ispartof British journal of psychiatry, 2016-11, Vol.209 (5), p.361-365
issn 0007-1250
1472-1465
language eng
recordid cdi_proquest_miscellaneous_1891867024
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Applied Social Sciences Index & Abstracts (ASSIA); Alma/SFX Local Collection; Cambridge University Press Journals Complete
subjects Analysis
Antipsychotic Agents - administration & dosage
Antipsychotic Agents - adverse effects
Antipsychotic Agents - pharmacology
Antipsychotics
Brain research
Brain structure
Diabetes
Dopamine
Dopamine D2 receptors
Drug dosages
Drug use
Health status
Humans
Long term
Mental disorders
Mortality
NMR
Nuclear magnetic resonance
Nutrition research
Physical training
Psychiatrists
Psychiatry
Psychosis
Psychotic Disorders - prevention & control
Psychotropic drugs
Schizophrenia
Schizophrenia - prevention & control
Secondary Prevention - standards
Side effects
title Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T20%3A21%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Should%20psychiatrists%20be%20more%20cautious%20about%20the%20long-term%20prophylactic%20use%20of%20antipsychotics?&rft.jtitle=British%20journal%20of%20psychiatry&rft.au=Murray,%20Robin%20M.&rft.date=2016-11&rft.volume=209&rft.issue=5&rft.spage=361&rft.epage=365&rft.pages=361-365&rft.issn=0007-1250&rft.eissn=1472-1465&rft_id=info:doi/10.1192/bjp.bp.116.182683&rft_dat=%3Cproquest_cross%3E2315619302%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2315619302&rft_id=info:pmid/27802977&rft_cupid=10_1192_bjp_bp_116_182683&rfr_iscdi=true